·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊÆ÷ÀÎÆ®¸ôTVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ÇѾà»ç 99¸í ¹èÃ⡦¿ø±¤´ë ±èÁö¼ö ¾¾ ¼ö¼® ±â»çÀÔ·Â : 19.01.23 18:49:01 2 °¡ ÇÃÄ£Ãß°¡ ±¹½Ã¿ø, 20ȸ ÇѾà»ç ±¹½Ã ÇÕ°ÝÀÚ °ø°³¡¦ÇÕ°Ý·ü 81.1% ¿ÃÇØ ÇѾà»ç ±¹½Ã¸¦ ÅëÇØ »õ³»±â ÇѾà»ç 99¸íÀÌ ¹èÃâµÆ´Ù. Çѱ¹º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿ø(¿øÀå ±èâÈÖ, ÀÌÇÏ ±¹½Ã¿ø)Àº 23ÀÏ Áö³ 10ÀϺÎÅÍ 11ÀϱîÁö ¼¿ï µî Àü±¹ 6°³ Áö¿ª, 8°³ ½ÃÇèÀå¿¡¼ ½ÃÇàµÈ Á¦20ȸ ÇѾà»ç ±¹°¡½ÃÇè °á°ú¸¦ ¹ßÇ¥Çß´Ù. ±¹½Ã¿øÀº ¿ÃÇØ ÇѾà»ç ±¹½Ã Àüü 122¸íÀÇ ÀÀ½ÃÀÚ Áß 99¸íÀÌ ÇÕ°Ý, 81.1%ÀÇ ÇÕ°Ý·üÀ» ±â·ÏÇß´Ù°í ¹àÇû´Ù. Áö³ÇØ ÇÕ°Ý·üÀº 90.9%·Î 9.8% Ç϶ôÇÑ ¼öÄ¡´Ù. ¿ÃÇØ ÇѾà»ç ±¹½Ã ¼ö¼®ÇÕ°ÝÀº 250Á¡ ¸¸Á¡¿¡ 227Á¡(90.8Á¡/100Á¡ ȯ»ê ±âÁØ)À» ÃëµæÇÑ ¿ø±¤´ë ±èÁö¼ö ¾¾°¡ Â÷ÁöÇß´Ù. ÇÑÆí À̹ø ÇѾà»ç ±¹°¡½ÃÇè ÇÕ°Ý¿©ºÎ´Â ±¹½Ã¿ø ȨÆäÀÌÁö(www.kuksiwon.or.kr)¿Í ¸ð¹ÙÀÏ È¨ÆäÀÌÁö(m.kuksiwon.or.kr), ÇÕ°ÝÀÚ¹ßÇ¥ ÈÄ 10ÀÏ°£ ARS(060-700-2353)¸¦ ÅëÇØ È®ÀÎÀÌ °¡´ÉÇÏ´Ù. ±¹½Ã¿øÀº ¿ø¼Á¢¼ö ½Ã ¿¬¶ôó¸¦ ±âÀçÇÑ ÀÀ½ÃÀÚ¿¡ ÇÑÇØ ¹®ÀÚ¸Þ½ÃÁö¸¦ ÅëÇؼµµ Á÷Á¢ ÇÕ°Ý¿©ºÎ¸¦ ¾Ë·ÁÁÙ ¿¹Á¤À̶ó°í ¹àÇû´Ù. ±èÁöÀº ±âÀÚ(bob83@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Senior Clinical Research Associate ¹Ù·Î°¡±â µµ¸Å»ó °ü¸® ¾à»ç´Ô ¸ð½Ê´Ï´Ù. ¹Ù·Î°¡±â Sr. RA Specialist, RA Speaiclist ä¿ë ¹Ù·Î°¡±â Medical ¹× Clinical °¢ ºÎ¹® ä¿ë ¹Ù·Î°¡±â BD¶óÀ̼¾½ÌÆÀ ½ÅÀÔ/°æ·Â»ç¿ø ¸ðÁý ¹Ù·Î°¡±â µ¿±¹»ý¸í°úÇÐ(ÁÖ) ¸¶ÄÉÆà ¾à»ç ¹× ¿¬±¸°³¹ß ¾à»ç ¿Ü ä¿ë ¹Ù·Î°¡±â [Á¦Á¶°ü¸®¾à»ç/Ç°Áú°ü¸®¾à»ç]Áß°ßÁ¦¾à»ç(ÆòÅÃ) ¹Ù·Î°¡±â 2024³â »ó¹Ý±â ¼ö½Ãä¿ë ¹Ù·Î°¡±â 2024³â Á¦3Â÷ Á÷¿øä¿ë Àç°ø°í ¹Ù·Î°¡±â µðÁöÅÐÇコÄɾî / Market Access / OTC¸¶ÄÉÆà / ÀÇ·á±â±â ¹Ù·Î°¡±â [CSL Behring] Medical Representative ¹Ù·Î°¡±â Medical Communication & Strategy ¹Ù·Î°¡±â [CSL Behring] Marketing Product Manager ¹Ù·Î°¡±â µµ¸Å¾à»ç´Ô ¸ð½Ê´Ï´Ù ¹Ù·Î°¡±â HLBÁ¦¾à ¾à»ç(RA) ä¿ë ¹Ù·Î°¡±â Ç°Áú°ü¸®¾à»ç / Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â °¨ÃÊ ½ÖÈÅÁÀº ÇѹæÁ¦Á¦ ÀÔ´Ï´Ù 19.01.24 21:57:29 0 ¼öÁ¤ »èÁ¦ 0 0 ±èÀÎÈ£ ¾ÆÁ÷µµ ¹èÃâµÇ°íÀÖ´Ù´Ï.... º¸°ÇÀη °èȹÀ» ´Ù½Ã Á¡°ËÇÏ°í ¿¬Âø·úÀ» ÅëÇÑ ÅëÇÕÀÌ ÇÊ¿äÇÏ´Ù°í »ý°¢µÇ´Âµ¥....... °ü·Ã ´ç±¹Àº °è¼Ó ÀÌ·¸°Ô ¹æÄ¡ÇØ µÑ°ÍÀÌ°¡? 19.01.24 09:28:28 0 ¼öÁ¤ »èÁ¦ 4 1 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÇѾà»ç 99¸í ¹èÃ⡦¿ø±¤´ë ±èÁö¼ö ¾¾ ¼ö¼® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÇѾà»ç 99¸í ¹èÃ⡦¿ø±¤´ë ±èÁö¼ö ¾¾ ¼ö¼® ±â»çÀÔ·Â : 19.01.23 18:49:01 2 °¡ ÇÃÄ£Ãß°¡ ±¹½Ã¿ø, 20ȸ ÇѾà»ç ±¹½Ã ÇÕ°ÝÀÚ °ø°³¡¦ÇÕ°Ý·ü 81.1% ¿ÃÇØ ÇѾà»ç ±¹½Ã¸¦ ÅëÇØ »õ³»±â ÇѾà»ç 99¸íÀÌ ¹èÃâµÆ´Ù. Çѱ¹º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿ø(¿øÀå ±èâÈÖ, ÀÌÇÏ ±¹½Ã¿ø)Àº 23ÀÏ Áö³ 10ÀϺÎÅÍ 11ÀϱîÁö ¼¿ï µî Àü±¹ 6°³ Áö¿ª, 8°³ ½ÃÇèÀå¿¡¼ ½ÃÇàµÈ Á¦20ȸ ÇѾà»ç ±¹°¡½ÃÇè °á°ú¸¦ ¹ßÇ¥Çß´Ù. ±¹½Ã¿øÀº ¿ÃÇØ ÇѾà»ç ±¹½Ã Àüü 122¸íÀÇ ÀÀ½ÃÀÚ Áß 99¸íÀÌ ÇÕ°Ý, 81.1%ÀÇ ÇÕ°Ý·üÀ» ±â·ÏÇß´Ù°í ¹àÇû´Ù. Áö³ÇØ ÇÕ°Ý·üÀº 90.9%·Î 9.8% Ç϶ôÇÑ ¼öÄ¡´Ù. ¿ÃÇØ ÇѾà»ç ±¹½Ã ¼ö¼®ÇÕ°ÝÀº 250Á¡ ¸¸Á¡¿¡ 227Á¡(90.8Á¡/100Á¡ ȯ»ê ±âÁØ)À» ÃëµæÇÑ ¿ø±¤´ë ±èÁö¼ö ¾¾°¡ Â÷ÁöÇß´Ù. ÇÑÆí À̹ø ÇѾà»ç ±¹°¡½ÃÇè ÇÕ°Ý¿©ºÎ´Â ±¹½Ã¿ø ȨÆäÀÌÁö(www.kuksiwon.or.kr)¿Í ¸ð¹ÙÀÏ È¨ÆäÀÌÁö(m.kuksiwon.or.kr), ÇÕ°ÝÀÚ¹ßÇ¥ ÈÄ 10ÀÏ°£ ARS(060-700-2353)¸¦ ÅëÇØ È®ÀÎÀÌ °¡´ÉÇÏ´Ù. ±¹½Ã¿øÀº ¿ø¼Á¢¼ö ½Ã ¿¬¶ôó¸¦ ±âÀçÇÑ ÀÀ½ÃÀÚ¿¡ ÇÑÇØ ¹®ÀÚ¸Þ½ÃÁö¸¦ ÅëÇؼµµ Á÷Á¢ ÇÕ°Ý¿©ºÎ¸¦ ¾Ë·ÁÁÙ ¿¹Á¤À̶ó°í ¹àÇû´Ù. ±èÁöÀº ±âÀÚ(bob83@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Senior Clinical Research Associate ¹Ù·Î°¡±â µµ¸Å»ó °ü¸® ¾à»ç´Ô ¸ð½Ê´Ï´Ù. ¹Ù·Î°¡±â Sr. RA Specialist, RA Speaiclist ä¿ë ¹Ù·Î°¡±â Medical ¹× Clinical °¢ ºÎ¹® ä¿ë ¹Ù·Î°¡±â BD¶óÀ̼¾½ÌÆÀ ½ÅÀÔ/°æ·Â»ç¿ø ¸ðÁý ¹Ù·Î°¡±â µ¿±¹»ý¸í°úÇÐ(ÁÖ) ¸¶ÄÉÆà ¾à»ç ¹× ¿¬±¸°³¹ß ¾à»ç ¿Ü ä¿ë ¹Ù·Î°¡±â [Á¦Á¶°ü¸®¾à»ç/Ç°Áú°ü¸®¾à»ç]Áß°ßÁ¦¾à»ç(ÆòÅÃ) ¹Ù·Î°¡±â 2024³â »ó¹Ý±â ¼ö½Ãä¿ë ¹Ù·Î°¡±â 2024³â Á¦3Â÷ Á÷¿øä¿ë Àç°ø°í ¹Ù·Î°¡±â µðÁöÅÐÇコÄɾî / Market Access / OTC¸¶ÄÉÆà / ÀÇ·á±â±â ¹Ù·Î°¡±â [CSL Behring] Medical Representative ¹Ù·Î°¡±â Medical Communication & Strategy ¹Ù·Î°¡±â [CSL Behring] Marketing Product Manager ¹Ù·Î°¡±â µµ¸Å¾à»ç´Ô ¸ð½Ê´Ï´Ù ¹Ù·Î°¡±â HLBÁ¦¾à ¾à»ç(RA) ä¿ë ¹Ù·Î°¡±â Ç°Áú°ü¸®¾à»ç / Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â °¨ÃÊ ½ÖÈÅÁÀº ÇѹæÁ¦Á¦ ÀÔ´Ï´Ù 19.01.24 21:57:29 0 ¼öÁ¤ »èÁ¦ 0 0 ±èÀÎÈ£ ¾ÆÁ÷µµ ¹èÃâµÇ°íÀÖ´Ù´Ï.... º¸°ÇÀη °èȹÀ» ´Ù½Ã Á¡°ËÇÏ°í ¿¬Âø·úÀ» ÅëÇÑ ÅëÇÕÀÌ ÇÊ¿äÇÏ´Ù°í »ý°¢µÇ´Âµ¥....... °ü·Ã ´ç±¹Àº °è¼Ó ÀÌ·¸°Ô ¹æÄ¡ÇØ µÑ°ÍÀÌ°¡? 19.01.24 09:28:28 0 ¼öÁ¤ »èÁ¦ 4 1 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÇѾà»ç 99¸í ¹èÃ⡦¿ø±¤´ë ±èÁö¼ö ¾¾ ¼ö¼® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÇѾà»ç 99¸í ¹èÃ⡦¿ø±¤´ë ±èÁö¼ö ¾¾ ¼ö¼® ±â»çÀÔ·Â : 19.01.23 18:49:01 2 °¡ ÇÃÄ£Ãß°¡ ±¹½Ã¿ø, 20ȸ ÇѾà»ç ±¹½Ã ÇÕ°ÝÀÚ °ø°³¡¦ÇÕ°Ý·ü 81.1% ¿ÃÇØ ÇѾà»ç ±¹½Ã¸¦ ÅëÇØ »õ³»±â ÇѾà»ç 99¸íÀÌ ¹èÃâµÆ´Ù. Çѱ¹º¸°ÇÀÇ·áÀα¹°¡½ÃÇè¿ø(¿øÀå ±èâÈÖ, ÀÌÇÏ ±¹½Ã¿ø)Àº 23ÀÏ Áö³ 10ÀϺÎÅÍ 11ÀϱîÁö ¼¿ï µî Àü±¹ 6°³ Áö¿ª, 8°³ ½ÃÇèÀå¿¡¼ ½ÃÇàµÈ Á¦20ȸ ÇѾà»ç ±¹°¡½ÃÇè °á°ú¸¦ ¹ßÇ¥Çß´Ù. ±¹½Ã¿øÀº ¿ÃÇØ ÇѾà»ç ±¹½Ã Àüü 122¸íÀÇ ÀÀ½ÃÀÚ Áß 99¸íÀÌ ÇÕ°Ý, 81.1%ÀÇ ÇÕ°Ý·üÀ» ±â·ÏÇß´Ù°í ¹àÇû´Ù. Áö³ÇØ ÇÕ°Ý·üÀº 90.9%·Î 9.8% Ç϶ôÇÑ ¼öÄ¡´Ù. ¿ÃÇØ ÇѾà»ç ±¹½Ã ¼ö¼®ÇÕ°ÝÀº 250Á¡ ¸¸Á¡¿¡ 227Á¡(90.8Á¡/100Á¡ ȯ»ê ±âÁØ)À» ÃëµæÇÑ ¿ø±¤´ë ±èÁö¼ö ¾¾°¡ Â÷ÁöÇß´Ù. ÇÑÆí À̹ø ÇѾà»ç ±¹°¡½ÃÇè ÇÕ°Ý¿©ºÎ´Â ±¹½Ã¿ø ȨÆäÀÌÁö(www.kuksiwon.or.kr)¿Í ¸ð¹ÙÀÏ È¨ÆäÀÌÁö(m.kuksiwon.or.kr), ÇÕ°ÝÀÚ¹ßÇ¥ ÈÄ 10ÀÏ°£ ARS(060-700-2353)¸¦ ÅëÇØ È®ÀÎÀÌ °¡´ÉÇÏ´Ù. ±¹½Ã¿øÀº ¿ø¼Á¢¼ö ½Ã ¿¬¶ôó¸¦ ±âÀçÇÑ ÀÀ½ÃÀÚ¿¡ ÇÑÇØ ¹®ÀÚ¸Þ½ÃÁö¸¦ ÅëÇؼµµ Á÷Á¢ ÇÕ°Ý¿©ºÎ¸¦ ¾Ë·ÁÁÙ ¿¹Á¤À̶ó°í ¹àÇû´Ù. ±èÁöÀº ±âÀÚ(bob83@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
°¨ÃÊ ½ÖÈÅÁÀº ÇѹæÁ¦Á¦ ÀÔ´Ï´Ù 19.01.24 21:57:29 0 ¼öÁ¤ »èÁ¦ 0 0 ±èÀÎÈ£ ¾ÆÁ÷µµ ¹èÃâµÇ°íÀÖ´Ù´Ï.... º¸°ÇÀη °èȹÀ» ´Ù½Ã Á¡°ËÇÏ°í ¿¬Âø·úÀ» ÅëÇÑ ÅëÇÕÀÌ ÇÊ¿äÇÏ´Ù°í »ý°¢µÇ´Âµ¥....... °ü·Ã ´ç±¹Àº °è¼Ó ÀÌ·¸°Ô ¹æÄ¡ÇØ µÑ°ÍÀÌ°¡? 19.01.24 09:28:28 0 ¼öÁ¤ »èÁ¦ 4 1 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÇѾà»ç 99¸í ¹èÃ⡦¿ø±¤´ë ±èÁö¼ö ¾¾ ¼ö¼® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö